Clinical Trials Directory

Trials / Completed

CompletedNCT03934411

Effect of Increased Pain Tolerance on Exercise Performance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
Male
Age
18 Years – 39 Years
Healthy volunteers
Accepted

Summary

Clinical prescription and use of opioids is a clear problem in large parts of the world and has the recent years received an increasing publicity in sports. This is in particular due to the World Anti-Doping Agency monitoring list, which reveal that endurance athletes utilize the opioid Tramadol frequently with the aim to enhance performance according to anecdotal evidence. Studies investigating the effect of tramadol on exercise performance in healthy humans is limited to one study in moderate trained subjects. However, this effect may be different in highly trained subjects due to the effects of chronic exercise. Furthermore, ingestion of tramadol may impact motor-cognitive performance and it remains unknown whether tramadol can be detected in highly trained subjects following exercise. In the present study the investigators apply a randomized double-blind placebo-controlled counterbalanced cross-over design to investigate whether tramadol treatment improves a preloaded cycling time trial performance, whether it affects motor-cognitive performance and whether it is detectable following exercise.

Conditions

Interventions

TypeNameDescription
DRUGTramadolThe subjects will orally ingest 100 mg tramadol retard actavis
OTHERPlaceboThe subjects will orally ingest 100 mg calcium powder

Timeline

Start date
2018-03-01
Primary completion
2019-03-07
Completion
2019-03-07
First posted
2019-05-01
Last updated
2019-05-01

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03934411. Inclusion in this directory is not an endorsement.